Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuehong Ren

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
1,2-Dimeth-oxy-3-[(E)-2-nitro-ethen-yl]benzeneYuehong Ren, Ruitao Zhu
Acta Crystallographica. Section E, Structure Reports Online|December 27, 2011
N-(Naphthalen-1-yl)benzamideRuitao Zhu, Yuehong Ren, Wenjuan Li
Acta Crystallographica. Section E, Structure Reports Online|June 22, 2012
N-(4-Bromo-benzyl-idene)naphthalen-1-amineRuitao Zhu, Yuehong Ren, Yuewen Zhang
Acta Pharmaceutica Sinica. B|July 10, 2023
The feasibility of oral targeted drug delivery: Gut immune to particulates?Yuehong Ren, Wei Wu, Xingwang Zhang
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
N-(4-Chloro-benzyl-idene)-1-naphthyl-amineRuitao Zhu, Yuewen Zhang, Yuehong Ren
International Journal of Nanomedicine|October 20, 2022
Nanovesicles-Mediated Drug Delivery for Oral Bioavailability EnhancementYuehong Ren, Linghui Nie, Shiping Zhu, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
3,5-Dinitro-N-(4-nitro-phen-yl)benzamideYuehong Ren, Yu Zuo, Yonggang Xiang, et al.
Acta Crystallographica. Section E, Structure Reports Online|November 9, 2011
N,N'-Bis(2,5-dichloro-phen-yl)isophthalamideRuitao Zhu, Jinlong Dong, Yu Zuo, et al.
International Journal of Nanomedicine|December 30, 2022
Advancement in Therapeutic Intervention of Prebiotic-Based Nanoparticles for Colonic DiseasesYuehong Ren, Linghui Nie, Chunhua Luo, et al.
Journal of Hazardous Materials|October 15, 2020
The exploration of metal-free catalyst g-C<sub>3</sub>N<sub>4</sub> for NO degradationYuehong Ren, Qingzhen Han, Yuehong Zhao, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
1,2-Dimeth-oxy-3-[(E)-2-nitro-ethen-yl]benzeneYuehong Ren, Ruitao Zhu
Acta Crystallographica. Section E, Structure Reports Online|December 27, 2011
N-(Naphthalen-1-yl)benzamideRuitao Zhu, Yuehong Ren, Wenjuan Li
Acta Crystallographica. Section E, Structure Reports Online|June 22, 2012
N-(4-Bromo-benzyl-idene)naphthalen-1-amineRuitao Zhu, Yuehong Ren, Yuewen Zhang
Acta Pharmaceutica Sinica. B|July 10, 2023
The feasibility of oral targeted drug delivery: Gut immune to particulates?Yuehong Ren, Wei Wu, Xingwang Zhang
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
N-(4-Chloro-benzyl-idene)-1-naphthyl-amineRuitao Zhu, Yuewen Zhang, Yuehong Ren
International Journal of Nanomedicine|October 20, 2022
Nanovesicles-Mediated Drug Delivery for Oral Bioavailability EnhancementYuehong Ren, Linghui Nie, Shiping Zhu, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
3,5-Dinitro-N-(4-nitro-phen-yl)benzamideYuehong Ren, Yu Zuo, Yonggang Xiang, et al.
Acta Crystallographica. Section E, Structure Reports Online|November 9, 2011
N,N'-Bis(2,5-dichloro-phen-yl)isophthalamideRuitao Zhu, Jinlong Dong, Yu Zuo, et al.
International Journal of Nanomedicine|December 30, 2022
Advancement in Therapeutic Intervention of Prebiotic-Based Nanoparticles for Colonic DiseasesYuehong Ren, Linghui Nie, Chunhua Luo, et al.
Journal of Hazardous Materials|October 15, 2020
The exploration of metal-free catalyst g-C<sub>3</sub>N<sub>4</sub> for NO degradationYuehong Ren, Qingzhen Han, Yuehong Zhao, et al.
Pageof 2